TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mother-infant bonding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: parental anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite of death, serious adverse events, or clinical grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Control of disease activity and prevention of flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stakeholder engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall satisfaction with roles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Belief in program success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive effects of nicotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade ≥ 2 symptomatic toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: baseline triglycerides (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 4 h triglycerides (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: baseline glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participant attendance at G-ACTp sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Service-use reductions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinically relevant seroma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Immediate patient response to portioning pauses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on survival outcome
Endpoint domain: Mortality/survival
Primary endpoint: Gastric retention of the glucose drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of systemic appearance of oral glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peripheral neuropathy incidence
Endpoint domain: Adverse events/effects
Primary endpoint: BPI global score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: BSND mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: global score of AT change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-report BRIEF-A GEC T-score change from baseline at week 10/ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD-RS-AP-TS change from baseline at week 10/ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occipital alpha power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cutaneous barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ceramide level in the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sweating ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global ADL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total of vocal acts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential gene expression in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of target attainment (PTA) for Streptococcus agalactiae and Listeria monocytogenes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum amoxicillin concentration associated with potential neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: IPSS score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: IIEF-5 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Need for component separation technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: New onset urinary incontinence (UI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ‐UI‐SF sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of the NURD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baPWV changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total distance to exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain control on the subsequent day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score for the cognitive section of the Bayley III test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of successful peripheral venous cannulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: esaxerenone peak plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean half-life of esaxerenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estradiol, prolactin, and follicle‐stimulating hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: uterine size and endometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increased risk of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rate of hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of IPV perpetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle proprioception improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female sexual function index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: partial responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stable diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cesarean delivery rates
Endpoint domain: Mortality/survival
Primary endpoint: Maternal headache incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical chorioamnionitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: SF-36 mental health score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: postoperative delirium incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mesial CBL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distal CBL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of adaptive behavioral strategies generated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of generating at least one adaptive cognitive strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for avoiding pain in similar situations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum overnight pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ODI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in VAS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chemotherapy-induced myelosuppression (CIM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prognosis improvement
Endpoint domain: Mortality/survival
Primary endpoint: Risk of new strokes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Higher mRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Validity of VASES for interpreting pharyngeal residue, penetration, and aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bond strength of conventional glass-ionomer cement to dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cough VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime CSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Night-time CSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased risk of hematoma growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Higher rate of functional independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time-to-first delirium remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of delirium-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in ADLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in IADLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNCV and MNCV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: composite outcome rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median pharyngeal contractile pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velopharyngeal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper oesophageal sphincter relaxation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete pain relief rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to undergo shoulder surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IGA 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥1 AE
Endpoint domain: Adverse events/effects
Primary endpoint: Serum GFAP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum NFL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinician cooperation with care manager
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Knowledge of care manager assignment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive perception of care manager implementation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of Major Depressive Disorder (MDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Complicated Grief (CG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of EZ defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident reoperations
Endpoint domain: Adverse events/effects
Primary endpoint: Exercise-induced gastrointestinal symptoms (EIGS) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastrointestinal symptom (GIS) severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of exacerbations requiring emergency visit and steroid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of children with well‐controlled asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to re-donation within 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma glucose excursions after oral glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting glucagon concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of cardiopulmonary bypass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Practice score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: worsening of paresthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: peripheral sensory neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cold temperature-induced pain in extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain with VR insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Concerns about VR cleanliness
Endpoint domain: Adverse events/effects
Primary endpoint: Mean serum 7‐alpha‐hydroxy‐4‐cholesten‐3‐one (C4) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in serum total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in low-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erection Hardness Score (EHS) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Encounter Profile (SEP) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of whole blood interferon (IFN) gene signature expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in migraine pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attachment loss after therapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of compressions with adequate depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived care burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: composite neonatal outcome of death or serious outcome
Endpoint domain: Mortality/survival
Primary endpoint: Limitation in social participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: improvements at the primary efficacy endpoint
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: functional health literacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oncofertility knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of anemia and need for blood transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: use of antibiotics and analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean reduction in plasma glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma glucose times in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time above range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in Ki-67
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean change in TUNEL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: probability of achieving 5% weight loss threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probability of achieving 10% weight loss threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of poststroke shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMT and CAS measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean proportion of opioid‐free urine drug screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retention in assigned treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year cumulative incidence of relapse
Endpoint domain: Mortality/survival
Primary endpoint: posterior tongue strength reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterioration in FACT-G
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deterioration in EQ5D-Visual Analogue Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased hearing thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of blood vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in emotional symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in peer problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite rate of death or HFH
Endpoint domain: Mortality/survival
Primary endpoint: Rate of non-therapeutic surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Intentional behavior improvement
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: opioid requirement within 24 h after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maintenance of biochemical response (IGF1 ≤ 1.0 × ULN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: hemoconcentration (increase in hematocrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: percent change in plasma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in delivered GTV D98%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiological outcomes
Primary endpoint: self estimated preparedness for practice
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: self-reported insomnia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cannabis-related problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cravings to use cannabis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reductions in binge drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived exercise benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of schistosome infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Success rate of caudal epidural block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of asthma diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction with virtual simulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RBCc increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hb increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hct increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: musculoskeletal pain prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Late complication occurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Capsular contracture
Endpoint domain: Adverse events/effects
Primary endpoint: Inframammary fold problems
Endpoint domain: Adverse events/effects
Primary endpoint: Mean visual acuity (VA) gain from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ocular/non-ocular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Self-efficacy (Total plus)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood oxygen level-dependent response to pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of stay in the PICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Chronic Pain Index (CMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transition competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction with the workshop
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional Independence Measure - motor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes